KRM AYURVEDA LIMITED Intrinsic Value
KRMAYURVED · Healthcare · Current price ₹296.7
Is KRM AYURVEDA LIMITED undervalued?
DocStoX estimates the fair value of KRM AYURVEDA LIMITED at ₹328 per share, versus the current market price of ₹297. That puts the stock about +10.5% below our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹245), Relative P/E (₹615), Graham floor (₹110). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹110 (bear) to ₹328 (base) to ₹615 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹297 versus an intrinsic value of ₹328, KRM AYURVEDA LIMITED currently offers +10.5% of margin.
More on KRM AYURVEDA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.